Chester County News and Community Website
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has filed a new composition of matter patent with the U.S. Patent and Trademark Office. This patent covers novel crystalline forms of …
Annovis Bio Files Patent for New Crystal Form of Buntanetap Read More
PLYMOUTH MEETING, PA — In a significant development for patients with Prader-Willi syndrome (PWS), Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently announced the initiation of a global Phase 3 registrational …
Harmony Biosciences Launches Phase 3 Trial for Potential Prader-Willi Syndrome Treatment Read More
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company based in Pennsylvania, has announced the receipt of an advanced milestone payment of $5 million from its partners, Alvogen, …
NRx Pharma Secures $5M Advance in Milestone Payment for Bipolar Depression Drug Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is making strategic moves, announcing several updates this week including promising trial results, a shift in drug development focus, and a significant …
Aclaris Therapeutics Advances ATI-1777 into Phase 2b Trial, Plans Workforce Reduction to Preserve Capital Read More
BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …
Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases, recently announced a significant milestone in its clinical trial journey. The …
Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward Read More
MALVERN, PA — In a significant corporate update, Chester County-based biotechnology firm Baudax Bio, Inc. (NASDAQ: BXRX) this week announced plans to initiate the clinical development of its groundbreaking therapy, …
Baudax Bio Prepares for Pioneering Clinical Development of TI-168, Aiming to Improve Hemophilia A Treatment Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced that the cooperative research and development agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) to evaluate Virpax’s …
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research Read More
MALVERN, PA — Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company, announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within …
Venatorx Pharmaceuticals Awarded a Third Antibiotic BARDA Contract Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it has engaged Dr. Pardeep Gupta, a leading expert in liposomal drug delivery and nanotechnology, to support the development of Probudur, Virpax’s …
Virpax Pharmaceuticals Enlists Leading Expert for Development of Pain Management Injectable Read More